As previously reported, Citi analyst Daniel Grosslight upgraded Phreesia to Buy from Neutral with a price target of $40, up from $28. He tells investors that he has been impressed by the company’s ability to accelerate growth this year and now sees "a clearer path to profitability."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PHR:
